DEF: BIO-key International Schedules 2025 Annual Meeting, Seeks Shareholder Approval for Director Elections and Expanded Equity Incentive Plans

BIO-key International, Inc. has filed its definitive proxy statement for its 2025 Annual Meeting of Stockholders, seeking approval for the election of five directors, ratification of its independent auditor, an advisory vote on executive compensation, and amendments to its 2023 Stock Incentive Plan and 2021 Employee Stock Purchase Plan.

Summary

• The 2025 Annual Meeting of Stockholders of BIO-key International, Inc. will be held on Friday, August 8, 2025, at 10:00 a.m., local time, at the company's offices in Holmdel, NJ.
• Stockholders of record at the close of business on June 20, 2025, are entitled to notice of and to vote at the Annual Meeting.
• Key proposals for the meeting include: the election of five members to the board of directors, ratification of Bush & Associates CPA LLC as the independent registered public accounting firm for the year ending December 31, 2025, an advisory vote on executive compensation, and approval of amendments to both the 2023 Stock Incentive Plan and the 2021 Employee Stock Purchase Plan.
• The proposed amendment to the 2023 Stock Incentive Plan seeks to increase the number of shares available for issuance by an additional 700,000 shares, bringing the total to 1,033,334 shares.
• The proposed amendment to the 2021 Employee Stock Purchase Plan aims to increase the number of shares available by 700,000 shares, totaling 743,834 shares, and raise the maximum purchase limit per participant to $25,000 per six-month offering period.
• As of June 20, 2025, there were 6,848,775 shares of the company's common stock issued and outstanding.
• The company previously restated its interim financial statements for the three, six, and nine months ended March 31, June 30, and September 30, 2023, respectively, due to errors that overstated accounts receivable and revenue, understated certain allowances and inventory reserves, and understated net loss and total stockholders' equity.
• A material weakness in internal control over financial reporting was identified for the fiscal year ended December 31, 2022, related to the review and control procedures over income tax provision and lack of control over foreign subsidiaries' timely tax return filings.

Sentiment

Score: 4

Explanation: The document is a standard proxy statement outlining routine corporate governance matters and proposed compensation plan amendments. However, the disclosures of past financial restatements, identified material weaknesses in internal controls, and persistent net losses, coupled with a noted misalignment of executive pay with Total Shareholder Return, indicate underlying operational and financial challenges. The proposed equity plan expansions, while positive for talent retention, also imply further potential dilution.

Positives

• The proposed amendments to the 2023 Stock Incentive Plan and 2021 Employee Stock Purchase Plan are intended to enhance the company's ability to attract, retain, and incentivize talent, aligning employee and executive interests with those of stockholders.
• The company's three-year average burn rate (2022-2024) for equity awards is approximately 3.60%, which is reported as lower than industry thresholds established by certain major proxy advisory firms, suggesting prudent management of equity dilution.
• The board of directors is composed of individuals with diverse and relevant experience in technology, accounting, finance, and international markets, including biometric industry expertise.
• The company has established robust corporate governance policies, including a Code of Ethics and an Insider Trading Policy, to promote ethical conduct and compliance.

Negatives

• The company was required to restate its previously issued interim financial statements for 2023 due to accounting errors, indicating issues with financial reporting accuracy.
• A material weakness in internal control over financial reporting was identified for the fiscal year ended December 31, 2022, specifically concerning income tax provision procedures and foreign subsidiary tax compliance.
• The compensation actually paid to the Principal Executive Officer (PEO) and Non-PEO Named Executive Officers (NEOs) was not aligned with the Total Shareholder Return (TSR) over the three years presented (2022-2024).
• The compensation actually paid to Non-PEO NEOs was also not aligned with the company's net loss over the three years presented.
• The company reported significant net losses for the past three fiscal years: $11,909,903 in 2022, $8,521,837 in 2023, and $4,300,692 in 2024.

Risks

• The company faces risks related to its internal control over financial reporting, as evidenced by the material weakness identified for the fiscal year ended December 31, 2022, particularly concerning income tax provision and foreign subsidiary tax filings.
• There is a risk of dilution for existing shareholders due to the proposed increase in shares available for issuance under the 2023 Stock Incentive Plan and 2021 Employee Stock Purchase Plan, which could impact per-share value.
• The company's ability to attract and retain qualified personnel is crucial, and while equity plans aim to mitigate this, competition for talent remains a challenge.
• The ongoing net losses indicate financial challenges that could impact the company's long-term sustainability and ability to continue as a going concern, as noted in previous audit reports.

Future Outlook

The document primarily focuses on corporate governance matters and proposed amendments to equity compensation plans for the upcoming annual meeting. It does not provide specific forward-looking financial guidance or business outlook beyond the general intent of the stock plans to attract and retain talent and align interests with stockholders.

Management Comments

• "It is important that your shares be represented at the meeting, regardless of the number of shares you hold and whether or not you plan to attend the meeting in person." Michael W. DePasquale, Chairman and CEO.
• "Our board of directors and management look forward to seeing you at the meeting. Thank you for your continued support." Michael W. DePasquale, Chairman and CEO.
• The board of directors believes the proposed plan amendment is in the best interests of the Company and its stockholders (regarding the 2023 Stock Incentive Plan amendment).
• We strongly believe in improving opportunities for our employees to reap the benefits of increases in our stocks value (regarding the 2021 Employee Stock Purchase Plan amendment).
• We believe that our continuing ability to offer shares under the ESPP improves our ability to attract, retain and incentivize our talent, and ultimately, better aligns the interests of our employees with those of our stockholders (regarding the 2021 Employee Stock Purchase Plan amendment).

Industry Context

BIO-key International operates in the technology sector, specializing in biometrics and identity management solutions. The company's reliance on equity incentive plans to attract and retain talent is a common practice in the competitive technology industry, where skilled professionals are highly sought after. The emphasis on aligning employee and shareholder interests through stock-based compensation reflects a standard approach for growth-oriented tech companies.

Comparison to Industry Standards

• The company's three-year average burn rate of approximately 3.60% is stated to be "lower than the industry thresholds established by certain major proxy advisory firms," suggesting a relatively conservative approach to equity dilution compared to broader industry benchmarks.
• The executive compensation structure, which includes base salary, performance-based cash bonuses, and long-term equity awards, is consistent with common industry practices. The company's stated goal of targeting total cash compensation within the average of peer companies, with base salaries slightly below and bonus opportunities slightly above, is a typical strategy to emphasize performance-based pay.
• The non-employee director compensation limit of $200,000 (or $300,000 for the board chair/lead independent director or in the initial service year) provides a specific benchmark for director remuneration, aligning with corporate governance best practices aimed at preventing excessive compensation.

Corporate Governance

Related Party Transactions

• The company has standstill agreements with Wong Kwok Fong (Kelvin) from October and November 2015, prohibiting him from acquiring additional shares, soliciting proxies, or seeking board representation.
• Michael W. DePasquale (Chairman and CEO), James D. Sullivan (SVP of Strategy and Compliance, Chief Legal Officer), and Mr. Sullivan's spouse participated in the company's public offering on October 31, 2023, purchasing shares and warrants.
• On November 27, 2024, the company entered into a securities purchase agreement with Fiber Food Systems, Inc., acquiring 5,000,000 shares of Boumarang, Inc. in exchange for 595,000 shares of BIO-key common stock, making Fiber Food a beneficial owner of over 5% of BIO-key's outstanding shares.
• The agreement with Fiber Food contemplates future collaboration on strategic and commercial transactions, including integrating BIO-key's identity access management solutions into Fiber Food's offerings and introducing BIO-key to Fiber Food's contacts.
• The Fiber Food purchase agreement includes a two-year standstill provision restricting business combinations, tender offers, proxy solicitations, or acquiring debt/equity securities of other parties by the company, Fiber Food, and Boumarang.

Stakeholder Impact

• Shareholders will directly impact corporate governance through their votes on director elections, auditor ratification, and executive compensation, and will experience potential dilution from the proposed expansion of equity incentive plans.
• Employees stand to benefit from the proposed amendments to the 2023 Stock Incentive Plan and 2021 Employee Stock Purchase Plan, which aim to provide enhanced opportunities for equity participation, potentially improving retention and motivation.
• Management and executives' compensation structure is detailed, with a focus on aligning pay with performance, although past misalignment with TSR is noted, which could affect their incentives and accountability.

Next Steps

• Stockholders are invited to attend and vote at the Annual Meeting on August 8, 2025.
• Stockholders will vote on the election of five directors to serve until the 2026 Annual Meeting.
• Stockholders will vote on the ratification of Bush & Associates CPA LLC as the independent registered public accounting firm for 2025.
• Stockholders will cast an advisory vote on executive compensation.
• Stockholders will vote on the proposed amendment to the BIO-key International, Inc. 2023 Stock Incentive Plan.
• Stockholders will vote on the proposed amendment to the BIO-key International, Inc. 2021 Employee Stock Purchase Plan.
• The company will continue discussions with Fiber Food Systems, Inc. and Boumarang regarding contemplated strategic and commercial collaborations.

Key Dates

Keywords

Proxy Statement, Annual Meeting, Stock Incentive Plan, Employee Stock Purchase Plan, Executive Compensation, Corporate Governance, SEC Filing, Shareholder Vote, Restatement, Internal Controls, Equity Compensation, Biometrics, Identity Management, Risk Management